Synairgen
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Mailpoint 810 Level F South Block Southa...Phone Number
+44 2380512800Website
www.synairgen.comRevenue
$12.2 MillionStock Symbol
SNGIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-, a naturally occurring protein that helps regulate the immune system to fight viruses, including coronaviruses.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Synairgen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Synairgen recently announced quarterly report
Check out if Synairgen is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Synairgen had a recent Job posting/layoffs
Check if Synairgen has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Synairgen
Funding: Get notified immidiatlly once Synairgen has new funding data
Product Launch: Get notified when Synairgen launches new products
Synairgen, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Synairgen as Masked Content
Find more new buyers
Compare Similar Companies to Synairgen
Compare insights from companies similar to Synairgen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Synairgen
$12.2M
11-50
Public
$34.5M
2003
N/A
Company Profile Activity
Activity Insights
Synairgen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Synairgen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Synairgen.
Synairgen financials insights
Gather financial insights about Synairgen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2004
Stock Offering
$12.5M
2025
Other Financing Round
$22M
Synairgen Tech Stack
A closer look at the technologies used by Synairgen
See more technologies
Synairgen News & Media
Synairgen life science company becomes latest to delist from Aim - The Times
The Southampton University spin-off will go private after struggling to raise funds for a clinical trialSynairgen Secures £18 Million Funding Amidst AIM Delisting Plans - TipRanks.com
An update from Synairgen ( ($GB:SNG) ) is now available. At a recent General Meeting, Synairgen plc announced the approval of all resolutions outlined in their Dece...Synairgen Secures £18 Million for Phase 2 Trial of SNG001 - TipRanks.com
Synairgen ( ($GB:SNG) ) has issued an update. Synairgen has successfully raised £18 million from TFG Asset Management to fund its Phase 2 INVENT clinical trial of S...Synairgen Share Chat. Chat About SNG Shares - Stock Quote, Charts, Trade History, Share ...
Synairgen Share Chat. Chat About SNG Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Synairgen
Sign Up For FreeTo access detailed company insights
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-, a naturally occurring protein that helps regulate the immune system to fight viruses, including coronaviruses.... Read More
